![DV1 DV1](https://data.pdbj.org/pdbjplus/data/cc/svg/DV1.svg) | DV1 | 表記: | (3~{a}~{R},5~{R},6~{S},7~{R},7~{a}~{R})-5-(hydroxymethyl)-2-(prop-2-enylamino)-5,6,7,7~{a}-tetrahydro-3~{a}~{H}-pyrano[3,2-d][1,3]thiazole-6,7-diol | 組成式: | C10 H16 N2 O4 S | SMILES: | OC[CH]1O[CH]2SC(=N[CH]2[CH](O)[CH]1O)NCC=C | InChi: | InChI=1S/C10H16N2O4S/c1-2-3-11-10-12-6-8(15)7(14)5(4-13)16-9(6)17-10/h2,5-9,13-15H,1,3-4H2,(H,11,12)/t5-,6-,7-,8-,9-/m1/s1 | 別名: | Propyleneaminothiazoline | 定義日: | 2015-10-21 | 最終更新日: | 2021-03-01 | 公開日: | 2016-08-31 | 識別子(ID): | (3aR,5R,6S,7R,7aR)-5-(hydroxymethyl)-2-(prop-2-enylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol |
|
![DXJ DXJ](https://data.pdbj.org/pdbjplus/data/cc/svg/DXJ.svg) | DXJ | 表記: | (3E,5E)-6,10-dimethylundeca-3,5,9-trien-2-one | 組成式: | C13 H20 O | SMILES: | [C@H](=CC(C)=O)C=C(CCC=C(C)C)C | InChi: | InChI=1S/C13H20O/c1-11(2)7-5-8-12(3)9-6-10-13(4)14/h6-7,9-10H,5,8H2,1-4H3/b10-6+,12-9+ | 別名: | Pseudoionone | 定義日: | 2017-11-10 | 最終更新日: | 2021-03-01 | 公開日: | 2018-01-24 | 識別子(ID): | (3E,5E)-6,10-dimethylundeca-3,5,9-trien-2-one |
|
![AES AES](https://data.pdbj.org/pdbjplus/data/cc/svg/AES.svg) | AES | 表記: | 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE | 組成式: | C8 H10 F N O2 S | SMILES: | O=S(F)(=O)c1ccc(cc1)CCN | InChi: | InChI=1S/C8H10FNO2S/c9-13(11,12)8-3-1-7(2-4-8)5-6-10/h1-4H,5-6,10H2 | 別名: | AEBSF | 定義日: | 2005-09-27 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-(2-aminoethyl)benzenesulfonyl fluoride |
|
![AET AET](https://data.pdbj.org/pdbjplus/data/cc/svg/AET.svg) | AET | 表記: | N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL)METHYLCARBAMOYL]THREONINE-5'-MONOPHOSPHATE | 組成式: | C16 H23 N6 O11 P | SMILES: | O=C(O)C(NC(=O)N(c3ncnc1c3ncn1C2OC(C(O)C2O)COP(=O)(O)O)C)C(O)C | InChi: | InChI=1S/C16H23N6O11P/c1-6(23)8(15(26)27)20-16(28)21(2)12-9-13(18-4-17-12)22(5-19-9)14-11(25)10(24)7(33-14)3-32-34(29,30)31/h4-8,10-11,14,23-25H,3H2,1-2H3,(H,20,28)(H,26,27)(H2,29,30,31)/t6-,7-,8+,10-,11-,14-/m1/s1 | 別名: | N-(NEBULARIN-6-YL-METHYLCARBAMOYL)-L-THREONINE-5'-MONOPHOSPHATE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R)-2-{[(9-{(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-9H-purin-6-yl)(methyl)carbamoyl]amino}-3-hydroxybutanoic acid (non-preferred name) |
|
![AF0 AF0](https://data.pdbj.org/pdbjplus/data/cc/svg/AF0.svg) | AF0 | 表記: | N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)methanesulfonamide | 組成式: | C20 H20 F4 N2 O3 S | SMILES: | c1(c(c(c(c(c1F)F)C)F)F)CS(Nc3cc2CCC(N(CCC)c2cc3)=O)(=O)=O | InChi: | InChI=1S/C20H20F4N2O3S/c1-3-8-26-15-6-5-13(9-12(15)4-7-16(26)27)25-30(28,29)10-14-19(23)17(21)11(2)18(22)20(14)24/h5-6,9,25H,3-4,7-8,10H2,1-2H3 | 別名: | AMF4 | 定義日: | 2017-05-15 | 最終更新日: | 2021-03-01 | 公開日: | 2017-11-15 | 識別子(ID): | N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)methanesulfonamide |
|
![AF9 AF9](https://data.pdbj.org/pdbjplus/data/cc/svg/AF9.svg) | AF9 | 表記: | 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide | 組成式: | C14 H19 N5 O4 S | SMILES: | COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1[S](N)(=O)=O | InChi: | InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19) | 別名: | AF-219 | 定義日: | 2017-12-05 | 最終更新日: | 2021-03-01 | 公開日: | 2018-04-04 | 識別子(ID): | 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide |
|
![AI7 AI7](https://data.pdbj.org/pdbjplus/data/cc/svg/AI7.svg) | AI7 | 表記: | 3-(heptyloxy)benzoic acid | 組成式: | C14 H20 O3 | SMILES: | O=C(O)c1cc(OCCCCCCC)ccc1 | InChi: | InChI=1S/C14H20O3/c1-2-3-4-5-6-10-17-13-9-7-8-12(11-13)14(15)16/h7-9,11H,2-6,10H2,1H3,(H,15,16) | 別名: | 3-heptyloxybenzoate | 定義日: | 2006-12-07 | 最終更新日: | 2021-03-01 | 識別子(ID): | 3-(heptyloxy)benzoic acid |
|
![AIT AIT](https://data.pdbj.org/pdbjplus/data/cc/svg/AIT.svg) | AIT | 表記: | (2S,3R)-3-(4-HYDROXYPHENYL)-2-(4-{[(2R)-2-PYRROLIDIN-1-YLPROPYL]OXY}PHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL | 組成式: | C27 H29 N O4 S | SMILES: | O2c5c(SC(c1ccc(O)cc1)C2c4ccc(OCC(N3CCCC3)C)cc4)cc(O)cc5 | InChi: | InChI=1S/C27H29NO4S/c1-18(28-14-2-3-15-28)17-31-23-11-6-19(7-12-23)26-27(20-4-8-21(29)9-5-20)33-25-16-22(30)10-13-24(25)32-26/h4-13,16,18,26-27,29-30H,2-3,14-15,17H2,1H3/t18-,26+,27-/m1/s1 | 別名: | COMPOUND 19 | 定義日: | 2004-10-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R)-3-(4-hydroxyphenyl)-2-(4-{[(2R)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-ol |
|
![AIU AIU](https://data.pdbj.org/pdbjplus/data/cc/svg/AIU.svg) | AIU | 表記: | (2S,3R)-2-(4-{2-[(3S,4S)-3,4-DIMETHYLPYRROLIDIN-1-YL]ETHOXY}PHENYL)-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL | 組成式: | C28 H31 N O4 S | SMILES: | O2c5c(SC(c1ccc(O)cc1)C2c4ccc(OCCN3CC(C)C(C)C3)cc4)cc(O)cc5 | InChi: | InChI=1S/C28H31NO4S/c1-18-16-29(17-19(18)2)13-14-32-24-10-5-20(6-11-24)27-28(21-3-7-22(30)8-4-21)34-26-15-23(31)9-12-25(26)33-27/h3-12,15,18-19,27-28,30-31H,13-14,16-17H2,1-2H3/t18-,19-,27+,28-/m1/s1 | 別名: | COMPOUND 16 | 定義日: | 2004-10-13 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R)-2-(4-{2-[(3S,4S)-3,4-dimethylpyrrolidin-1-yl]ethoxy}phenyl)-3-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzoxathiin-6-ol |
|
![AJU AJU](https://data.pdbj.org/pdbjplus/data/cc/svg/AJU.svg) | AJU | 表記: | 2,3,5,6,8,9,11,12,14,15-decahydro-1,4,7,10,13,16-benzohexaoxacyclooctadecine-18-carboxylic acid | 組成式: | C17 H24 O8 | SMILES: | O=C(O)c1ccc2c(c1)OCCOCCOCCOCCOCCO2 | InChi: | InChI=1S/C17H24O8/c18-17(19)14-1-2-15-16(13-14)25-12-10-23-8-6-21-4-3-20-5-7-22-9-11-24-15/h1-2,13H,3-12H2,(H,18,19) | 別名: | 4'-Carboxybenzo-18-crown 6-Ether | 定義日: | 2018-11-07 | 最終更新日: | 2021-03-01 | 公開日: | 2019-03-13 | 識別子(ID): | 2,3,5,6,8,9,11,12,14,15-decahydro-1,4,7,10,13,16-benzohexaoxacyclooctadecine-18-carboxylic acid |
|
![AKV AKV](https://data.pdbj.org/pdbjplus/data/cc/svg/AKV.svg) | AKV | 表記: | {3-[(1R,3S)-1,3-DIHYDROXYPENTYL]-4,5,9,10-TETRAHYDROXY-2-ANTHRYL}ACETATE | 組成式: | C22 H22 O8 | SMILES: | O=C2c1cccc(O)c1C(=O)c3c2cc(c(c3O)C(O)CC(O)CC)CC(=O)OC | InChi: | InChI=1S/C22H22O8/c1-3-11(23)9-15(25)17-10(8-16(26)30-2)7-13-19(21(17)28)22(29)18-12(20(13)27)5-4-6-14(18)24/h4-7,11,15,23-25,28H,3,8-9H2,1-2H3/t11-,15+/m0/s1 | 別名: | DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME) | 定義日: | 2006-02-07 | 最終更新日: | 2021-03-01 | 識別子(ID): | methyl {3-[(1R,3S)-1,3-dihydroxypentyl]-4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl}acetate |
|
![AL3 AL3](https://data.pdbj.org/pdbjplus/data/cc/svg/AL3.svg) | AL3 | 表記: | 3,4-DIHYDRO-4-HYDROXY-2-(2-THIENYMETHYL)-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE | 組成式: | C11 H12 N2 O5 S4 | SMILES: | O=S(=O)(c1sc3c(c1)C(O)CN(Cc2sccc2)S3(=O)=O)N | InChi: | InChI=1S/C11H12N2O5S4/c12-21(15,16)10-4-8-9(14)6-13(5-7-2-1-3-19-7)22(17,18)11(8)20-10/h1-4,9,14H,5-6H2,(H2,12,15,16)/t9-/m0/s1 | 別名: | AL5300 | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4R)-4-hydroxy-2-(thiophen-2-ylmethyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide |
|
![ALE ALE](https://data.pdbj.org/pdbjplus/data/cc/svg/ALE.svg) | ALE | 表記: | L-EPINEPHRINE | 組成式: | C9 H13 N O3 | SMILES: | Oc1ccc(cc1O)C(O)CNC | InChi: | InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 | 別名: | ADRENALINE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol |
|
![AM1 AM1](https://data.pdbj.org/pdbjplus/data/cc/svg/AM1.svg) | AM1 | 表記: | (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID | 組成式: | C8 H10 N2 O5 | SMILES: | O=C(O)c1noc(c1CC(C(=O)O)N)C | InChi: | InChI=1S/C8H10N2O5/c1-3-4(2-5(9)7(11)12)6(8(13)14)10-15-3/h5H,2,9H2,1H3,(H,11,12)(H,13,14) | 別名: | ACPA | 定義日: | 2002-07-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-(2-amino-2-carboxyethyl)-5-methylisoxazole-3-carboxylic acid |
|
![AOQ AOQ](https://data.pdbj.org/pdbjplus/data/cc/svg/AOQ.svg) | AOQ | 表記: | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione | 組成式: | C22 H19 Cl O3 | SMILES: | Clc1ccc(cc1)C4CCC(C=3C(=O)c2ccccc2C(=O)C=3O)CC4 | InChi: | InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,26H,5-8H2/t13-,15- | 別名: | Atovaquone | 定義日: | 2014-06-03 | 最終更新日: | 2021-03-01 | 公開日: | 2014-06-11 | 識別子(ID): | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione |
|
![AOX AOX](https://data.pdbj.org/pdbjplus/data/cc/svg/AOX.svg) | AOX | 表記: | (3Beta,5alpha)-3-Hydroxyandrostan-17-one | 組成式: | C19 H30 O2 | SMILES: | O=C2C1(CCC3C(C1CC2)CCC4C3(CCC(O)C4)C)C | InChi: | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,18-,19-/m0/s1 | 別名: | Epiandrosterone | 定義日: | 2011-12-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3S,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-3-oxidanyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one |
|
![AQ9 AQ9](https://data.pdbj.org/pdbjplus/data/cc/svg/AQ9.svg) | AQ9 | 表記: | 1-O-[(8alpha,9beta,10alpha,13alpha)-13-(beta-D-glucopyranosyloxy)-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose | 組成式: | C32 H50 O13 | SMILES: | C=C1/C5(CC4(C1)CCC3C(C(OC2OC(C(C(O)C2O)O)CO)=O)(C)CCCC3(C4CC5)C)OC6OC(CO)C(O)C(O)C6O | InChi: | InChI=1S/C32H50O13/c1-15-11-31-9-5-18-29(2,7-4-8-30(18,3)28(41)44-26-24(39)22(37)20(35)16(12-33)42-26)19(31)6-10-32(15,14-31)45-27-25(40)23(38)21(36)17(13-34)43-27/h16-27,33-40H,1,4-14H2,2-3H3/t16-,17-,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,29-,30-,31-,32+/m1/s1 | 別名: | Rubusoside | 定義日: | 2018-11-15 | 最終更新日: | 2021-03-01 | 公開日: | 2019-07-31 | 識別子(ID): | 1-O-[(8alpha,9beta,10alpha,13alpha)-13-(beta-D-glucopyranosyloxy)-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose |
|
![AQJ AQJ](https://data.pdbj.org/pdbjplus/data/cc/svg/AQJ.svg) | AQJ | 表記: | (3R,5R,6S,7S,9R,11E,13S,14R)-14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxo-1-oxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside | 組成式: | C28 H47 N O8 | SMILES: | C1(OC(C(C)C(C(C)C(C(C)CC(C(C=CC1(C)O)=O)C)OC2C(C(CC(C)O2)N(C)C)O)=O)=O)CC | InChi: | InChI=1S/C28H47NO8/c1-10-22-28(7,34)12-11-21(30)15(2)13-16(3)25(18(5)23(31)19(6)26(33)36-22)37-27-24(32)20(29(8)9)14-17(4)35-27/h11-12,15-20,22,24-25,27,32,34H,10,13-14H2,1-9H3/b12-11+/t15-,16+,17-,18+,19-,20+,22-,24-,25+,27+,28+/m1/s1 | 別名: | Pikromycin | 定義日: | 2017-07-24 | 最終更新日: | 2021-03-01 | 公開日: | 2018-02-14 | 識別子(ID): | (3R,5R,6S,7S,9R,11E,13S,14R)-14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxo-1-oxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside |
|
![ARJ ARJ](https://data.pdbj.org/pdbjplus/data/cc/svg/ARJ.svg) | ARJ | 表記: | (2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-2-hydroxy-5-(hydroxymethyl)cyclopentanone | 組成式: | C11 H13 N5 O3 | SMILES: | O=C3C(O)C(n1c2ncnc(c2nc1)N)CC3CO | InChi: | InChI=1S/C11H13N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h3-6,9,17,19H,1-2H2,(H2,12,13,14)/t5-,6-,9+/m1/s1 | 別名: | 3'-keto-aristeromycin | 定義日: | 2008-03-05 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-2-hydroxy-5-(hydroxymethyl)cyclopentanone |
|
![ARR ARR](https://data.pdbj.org/pdbjplus/data/cc/svg/ARR.svg) | ARR | 表記: | N-(4-{2-[(3-CHLOROBENZYL)AMINO]ETHYL}PHENYL)THIOPHENE-2-CARBOXIMIDAMIDE | 組成式: | C20 H20 Cl N3 S | SMILES: | Clc1cccc(c1)CNCCc3ccc(NC(=[N@H])c2sccc2)cc3 | InChi: | InChI=1S/C20H20ClN3S/c21-17-4-1-3-16(13-17)14-23-11-10-15-6-8-18(9-7-15)24-20(22)19-5-2-12-25-19/h1-9,12-13,23H,10-11,14H2,(H2,22,24) | 別名: | N-(4-(2-((3-CHLOROPHENYLMETHYL)AMINO)ETHYL)PHENYL)-2-THIOPHECARBOXAMIDINE | 定義日: | 2004-02-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide |
|
![ARX ARX](https://data.pdbj.org/pdbjplus/data/cc/svg/ARX.svg) | ARX | 表記: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(6-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]amino}-6-oxohexyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide | 組成式: | C28 H47 N15 O7 | SMILES: | O=C(N)C(NC(=O)C(NC(=O)CCCCCNC(=O)C3OC(n2cnc1c(ncnc12)N)C(O)C3O)CCCNC(=[N@H])N)CCCNC(=[N@H])N | InChi: | InChI=1S/C28H47N15O7/c29-21-17-23(39-12-38-21)43(13-40-17)26-19(46)18(45)20(50-26)25(49)35-9-3-1-2-8-16(44)41-15(7-5-11-37-28(33)34)24(48)42-14(22(30)47)6-4-10-36-27(31)32/h12-15,18-20,26,45-46H,1-11H2,(H2,30,47)(H,35,49)(H,41,44)(H,42,48)(H2,29,38,39)(H4,31,32,36)(H4,33,34,37)/t14-,15-,18+,19-,20+,26-/m1/s1 | 別名: | ARC-1034 | 定義日: | 2008-01-30 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3S,4R,5R)-N-(6-{[(2R)-1-{[(2R)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino}-5-carbamimidamido-1-oxopentan-2-yl]amino}-6-oxohexyl)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) |
|
![E40 E40](https://data.pdbj.org/pdbjplus/data/cc/svg/E40.svg) | E40 | 表記: | (2R)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-2-{[(4'-methoxybiphenyl-4-yl)sulfonyl](propan-2-yloxy)amino}butanamide | 組成式: | C28 H29 N3 O8 S | SMILES: | O=S(=O)(c2ccc(c1ccc(OC)cc1)cc2)N(OC(C)C)C(C(=O)NO)CCN4C(=O)c3ccccc3C4=O | InChi: | InChI=1S/C28H29N3O8S/c1-18(2)39-31(40(36,37)22-14-10-20(11-15-22)19-8-12-21(38-3)13-9-19)25(26(32)29-35)16-17-30-27(33)23-6-4-5-7-24(23)28(30)34/h4-15,18,25,35H,16-17H2,1-3H3,(H,29,32)/t25-/m1/s1 | 別名: | EN140 | 定義日: | 2014-11-22 | 最終更新日: | 2021-03-01 | 公開日: | 2015-08-26 | 識別子(ID): | (2R)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-2-{[(4'-methoxybiphenyl-4-yl)sulfonyl](propan-2-yloxy)amino}butanamide |
|
![E4B E4B](https://data.pdbj.org/pdbjplus/data/cc/svg/E4B.svg) | E4B | 表記: | ethyl 4-hydroxybenzoate | 組成式: | C9 H10 O3 | SMILES: | O=C(OCC)c1ccc(O)cc1 | InChi: | InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3 | 別名: | Ethyl p-hydroxybenzoate | 定義日: | 2012-05-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | ethyl 4-hydroxybenzoate |
|
![E4D E4D](https://data.pdbj.org/pdbjplus/data/cc/svg/E4D.svg) | E4D | 表記: | (2S,3R)-2-(4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)-2,3-DIHYDRO-3-(4-HYDROXYPHENYL)BENZO[B][1,4]OXATHIIN-6-OL | 組成式: | C27 H29 N O4 S | SMILES: | O2c5c(SC(c1ccc(O)cc1)C2c4ccc(OCCN3CCCCC3)cc4)cc(O)cc5 | InChi: | InChI=1S/C27H29NO4S/c29-21-8-4-20(5-9-21)27-26(32-24-13-10-22(30)18-25(24)33-27)19-6-11-23(12-7-19)31-17-16-28-14-2-1-3-15-28/h4-13,18,26-27,29-30H,1-3,14-17H2/t26-,27+/m0/s1 | 別名: | COMPOUND 4-D | 定義日: | 2004-03-10 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R)-3-(4-hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol |
|
![E4R E4R](https://data.pdbj.org/pdbjplus/data/cc/svg/E4R.svg) | E4R | 表記: | (3S,5R,8R,9S,10S,13S,14S,17S)-17-(furan-3-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol | 組成式: | C23 H34 O4 | SMILES: | C[C]12CC[CH](O)C[CH]1CC[CH]3[CH]2CC[C]4(C)[C]3(O)CC[C]4(O)c5cocc5 | InChi: | InChI=1S/C23H34O4/c1-20-8-5-17(24)13-15(20)3-4-19-18(20)6-9-21(2)22(25,10-11-23(19,21)26)16-7-12-27-14-16/h7,12,14-15,17-19,24-26H,3-6,8-11,13H2,1-2H3/t15-,17+,18+,19-,20+,21-,22+,23+/m1/s1 | 別名: | Rostafuroxin | 定義日: | 2019-10-16 | 最終更新日: | 2021-03-01 | 公開日: | 2020-09-02 | 識別子(ID): | (3~{S},5~{R},8~{R},9~{S},10~{S},13~{S},14~{S},17~{S})-17-(furan-3-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,15,16-dodecahydro-1~{H}-cyclopenta[a]phenanthrene-3,14,17-triol |
|